NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 199 filers reported holding NEKTAR THERAPEUTICS in Q4 2016. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $994,000 | +24.9% | 16,300 | 0.0% | 0.11% | +31.0% |
| Q2 2018 | $796,000 | -65.5% | 16,300 | -24.9% | 0.09% | -68.2% |
| Q1 2018 | $2,306,000 | +5.5% | 21,700 | -40.7% | 0.27% | -4.5% |
| Q4 2017 | $2,186,000 | +119.0% | 36,600 | -12.0% | 0.29% | +82.8% |
| Q3 2017 | $998,000 | +22.8% | 41,600 | 0.0% | 0.16% | +12.1% |
| Q2 2017 | $813,000 | -16.7% | 41,600 | 0.0% | 0.14% | -31.4% |
| Q1 2017 | $976,000 | +70.6% | 41,600 | -10.7% | 0.20% | +53.4% |
| Q4 2016 | $572,000 | -28.6% | 46,600 | 0.0% | 0.13% | -26.5% |
| Q3 2016 | $801,000 | -6.2% | 46,600 | -22.3% | 0.18% | -13.0% |
| Q2 2016 | $854,000 | +3.5% | 60,000 | 0.0% | 0.21% | +5.6% |
| Q1 2016 | $825,000 | -18.4% | 60,000 | 0.0% | 0.20% | -16.2% |
| Q4 2015 | $1,011,000 | – | 60,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
| Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
| Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
| Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
| BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
| First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
| Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
| SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
| QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
| Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |